I now have enough information to compile a comprehensive, interview-ready answer. Here is your complete GPSC interview preparation guide:
GPSC Interview Preparation - Complete Answer Bank
SECTION 1: COLD CHAIN & IMMUNIZATION MANAGEMENT
Q1. What is an ILR (Ice Lined Refrigerator) and what is it used for?
An ILR (Ice Lined Refrigerator) is a specialized refrigerator used at the PHC/CHC level in India's cold chain system. It is designed specifically to store vaccines safely between +2°C to +8°C.
Key features:
- Has an inner lining filled with water/ice packs that acts as a thermal buffer - if the electricity goes off, the ice lining keeps the temperature stable for 6-12 hours (some models up to 24 hours depending on ice pack fill and ambient temperature)
- The compressor is energy-efficient and built for tropical conditions
- Has a top-opening lid (most common type) to prevent cold air from escaping when opened
- Has a temperature alarm and an inbuilt thermometer
- Available in models: ILR-45, ILR-140, ILR-280 (numbers indicate approximate capacity in liters)
Used for: Storing all vaccines that require +2°C to +8°C, such as BCG, OPV, DPT, Hepatitis B, IPV, PCV, RVV, MR, and also vaccine diluents
Q2. How are vaccines arranged inside an ILR?
This is a practical operations question. The rule is based on freeze-sensitivity vs cold tolerance:
| Position | Vaccines Kept Here | Reason |
|---|
| Top baskets / upper shelves | Freeze-sensitive vaccines: DPT, Hepatitis B, DT, TT, IPV, Td | The top portion of the ILR is slightly warmer - protecting freeze-sensitive vaccines from freezing |
| Bottom / lower section | Freeze-tolerant vaccines: OPV, BCG, MR (Measles-Rubella), JE | These tolerate colder temperatures and can be kept at the bottom |
| Door shelves | NEVER store vaccines in door - temperature fluctuates too much here | Diluents can be placed in doors |
| Ice packs | Lie flat on the floor of the ILR lining | |
Golden Rule: DPT, HepB, DT, TT = TOP (Freeze-Sensitive = Stay at Top)
OPV, BCG = BOTTOM (Freeze-Tolerant = Bottom is fine)
Q3. Temperature range of a Deep Freezer - Can it store vaccines?
| Equipment | Temperature | Vaccine Storage? |
|---|
| Deep Freezer (DF) | -15°C to -25°C | Yes - for OPV and storage of ice packs |
| Ice Lined Refrigerator (ILR) | +2°C to +8°C | All other UIP vaccines |
| Cold Box | Up to 72 hours cold life | Transport/outreach |
| Vaccine Carrier | Up to 4-6 hours | Session sites |
The deep freezer is primarily used for:
- Storing OPV (Oral Polio Vaccine - highly heat labile, needs frozen storage)
- Freezing ice packs for use in vaccine carriers
Important: Freeze-sensitive vaccines (DPT, HepB, DT, TT, IPV) must NEVER be kept in a deep freezer - freezing destroys them permanently.
Q4. Managing vaccines during a severe power outage in a rural PHC
Step-by-step protocol:
-
Immediate action (within 1 hour):
- Check current temperature - if still within 2-8°C, vaccines are safe
- Activate emergency protocol - inform Cold Chain Officer (CCO) / District Cold Chain Officer (DCCO)
- Fill the ILR completely with conditioned ice packs to extend cold life
- Minimize door opening strictly
-
If power outage will extend beyond ILR cold life (6-12 hours for most ILRs):
- Contact the nearest functioning cold chain point (CHC/District Hospital)
- Arrange insulated cold boxes and vaccine carriers packed with ice packs
- Transfer vaccines in cold boxes with minimum handling, maintaining the cold chain throughout
-
Documentation:
- Record time of outage, temperature readings at each check (every 2-4 hours)
- Mark each vaccine vial's status - use VVM to assess if potency is intact
- Report to Block Medical Officer / District Cold Chain Officer
-
Alternate arrangements:
- Use solar-powered refrigerators (available in many PHCs under NHM)
- Contact nearby private cold storage if authorized
- Use generator backup if available at PHC
-
Upon restoration:
- Do NOT immediately place warm vaccines back - stabilize temperature first
- Document and report any suspected damaged stock
Q5. What is "Conditioning of an Ice Pack"?
Definition: Conditioning means allowing a freshly frozen ice pack (which is at -15°C to -25°C) to warm up slightly to 0°C before placing it in the vaccine carrier.
Why it is done:
Ice packs straight from the deep freezer are extremely cold (-20°C). If placed directly against vaccines in a carrier, they can freeze the vaccines - especially freeze-sensitive ones like DPT, HepB, TT, and IPV, permanently destroying them.
How to condition:
- Take the ice pack out of the deep freezer
- Hold it in your hands for a few seconds OR
- Leave it at room temperature for a few minutes
How to know an ice pack is properly conditioned and ready:
- You will hear a swishing sound when you shake the ice pack - this indicates the ice inside has partially melted and there is liquid water around the remaining ice
- Alternatively, water droplets appear on the outer surface of the ice pack (sweating)
- The ice pack should feel cold but NOT rock-solid frozen
- At this point (0°C), it is safe to place in the vaccine carrier
Q6. How many ice packs are placed in a standard vaccine carrier?
A standard vaccine carrier uses 4 conditioned ice packs - one on each of the four sides (bottom, two sides, and top/lid). The vaccines are placed in the center protected by the 4 ice packs.
Some newer models may vary slightly. The key principle is that vaccines must not directly touch ice packs - a foam separator or polybag can be used. The carrier provides approximately 4-6 hours of cold life at the session site.
Q7. What is "Bundling" in the context of vaccination?
Bundling is a strategy used in immunization sessions where all due vaccines for a child on that day are administered together in one visit, rather than asking the family to return for each vaccine separately.
Purpose:
- Reduces missed opportunities for immunization
- Reduces the number of visits a family has to make
- Improves full immunization coverage (FIC)
- Prevents dropouts
Example: A 14-week-old child should receive DPT-1, OPV-1, IPV, PCV, RVV, and HepB-2 on the same visit - all these are given together (bundled), not spread across multiple days.
Bundling is a key operational strategy emphasized in Intensified Mission Indradhanush (IMI).
Q8. What is the full form of eVIN and how does it work?
eVIN = Electronic Vaccine Intelligence Network
Developed by India's Ministry of Health & Family Welfare with support from UNDP and initially funded by Gavi. Now an open-source platform called eVIN Advance Edition.
How it works:
-
Hardware: Temperature loggers (nearly 25,000 installed across India) are placed inside all cold chain equipment (ILR, deep freezers, cold rooms) at cold chain points (CCPs)
-
Smartphone App: Cold chain handlers log vaccine stock transactions (receipt, issue, return, discard) in real time using a mobile application
-
Cloud Server: All data syncs to a central cloud-based dashboard accessible to state and national program managers
-
Temperature Monitoring: Temperature loggers send real-time alerts to designated staff via SMS/app if temperature goes outside the safe range (automated alert mechanism)
-
Stock Visibility: Program managers can see vaccine stock levels at every cold chain point in real time - enabling better forecasting, preventing stock-outs (>80% reduction in stock-outs achieved) and preventing overstocking
-
Coverage: Live in all 733 districts, 36 states/UTs. Over 29,000 vaccine storage centres are on the platform. Vaccine availability rate exceeds 99%.
-
Integration with U-WIN: eVIN's learnings were used to build CoWIN (COVID vaccination) and now U-WIN (beneficiary tracking portal for UIP)
Q9. Do vaccine diluents need to be kept in the ILR? When should they be placed?
Yes, diluents must be kept in the ILR, but with an important timing rule:
- Diluents are placed in the ILR 24 hours before the immunization session - not months in advance
- This ensures the diluent reaches the same temperature as the vaccine before reconstitution
- If a cold diluent is mixed with a cold lyophilized vaccine powder (like BCG, MR, JE), it prevents thermal shock
Why timing matters:
- Reconstituting a freeze-dried vaccine with a warm diluent can damage the vaccine
- Reconstituting with an ice-cold diluent (from ILR) is the correct practice
Storage of diluents: Can be stored at room temperature in the store until 24 hours before the session, then placed in the ILR (preferably on the door shelf or upper portion - NOT in contact with ice packs as some diluents are water-based and can freeze)
Q10. What is the Open Vial Policy (OVP)?
Definition: The Open Vial Policy (OVP) states that a multi-dose vaccine vial that has been opened can be used in subsequent sessions (up to 28 days or 4 weeks) provided certain conditions are met, rather than discarding it at the end of each session.
Conditions for continued use under OVP:
- The vial has not expired
- The vaccine was stored properly in ILR (2-8°C) at all times
- The VVM (Vaccine Vial Monitor) has not crossed the alarm stage
- The vaccine was not subjected to freezing (for freeze-sensitive vaccines)
- No contamination of the stopper - aseptic technique followed
- The vial label and batch number are intact
Primary purpose: To reduce vaccine wastage significantly. A 10-dose vial doesn't need to be discarded just because not all 10 children came on session day.
Q11. Which vaccines do NOT follow Open Vial Policy - must be discarded within 4 hours?
The following vaccines must be discarded within 4 hours of opening OR at the end of the session, whichever is earlier:
| Vaccine | Reason |
|---|
| BCG | Contains live bacteria + no preservative + highly susceptible to contamination and light |
| Measles-Rubella (MR) | Reconstituted vaccine - no preservative, degrades rapidly |
| JE (Japanese Encephalitis) vaccine | Reconstituted, live attenuated |
| OPV | Some formulations are sensitive; field practice varies |
Mnemonic: "BCG & all Reconstituted vaccines = 4 hours only"
These are lyophilized (freeze-dried) vaccines that must be reconstituted with a diluent before use. Once reconstituted, they are unstable and cannot be reused the next session.
All other multi-dose vials (DPT, HepB, OPV, PCV, DT, TT, Td) follow the OVP and can be reused in subsequent sessions within the same month, subject to conditions.
Q12. What is a VVM (Vaccine Vial Monitor)? Does it measure current or cumulative temperature?
VVM (Vaccine Vial Monitor) is a small heat-sensitive label/sticker placed on the vaccine vial cap or label. It is a square within a circle that changes color based on heat exposure.
Critically: VVM measures CUMULATIVE heat exposure over time - NOT the current temperature.
This is extremely important - it tells you the total amount of heat the vaccine has been exposed to throughout its entire lifetime from manufacture to use.
How it works:
- The inner square is initially lighter than the outer circle
- As the vaccine is exposed to heat, the inner square darkens progressively
- Reading:
- Inner square lighter than outer circle = SAFE to use (VVM 1 or 2)
- Inner square SAME color as outer circle = DO NOT USE (VVM 3 - at discard point)
- Inner square DARKER than outer circle = DISCARD immediately (VVM 4 - past discard point)
Key point for interview: VVM does NOT tell you about freezing damage. A vaccine can be frozen (damaged) but still have a good VVM. The Shake Test is used for that.
There are 4 types of VVMs (VVM2, VVM7, VVM14, VVM30) based on the number of days they are designed to last at a reference temperature.
Q13. What is the "Shake Test"? For which vaccines is it done?
The Shake Test is a field test used to determine whether a freeze-sensitive vaccine has been accidentally frozen and is therefore damaged.
Why needed: Freezing causes the adjuvant (aluminium salts) to coagulate/aggregate. This forms clumps but appears visually normal when you look at the vial. The vial looks fine but the vaccine is irreversibly damaged.
How to perform the Shake Test:
- Take two vials - one is the test vial (suspected frozen) and one is the control vial (a vial of the same vaccine that was definitely frozen intentionally and is thus known-damaged)
- Shake both vigorously for 10-15 seconds
- Hold both up to the light and observe sedimentation
Reading:
- If the test vial settles slower than the control vial (or settles at the same rate) = vaccine is DAMAGED (do not use)
- If the test vial settles faster than the control (clear supernatant forms quickly) = vaccine is SAFE to use
Vaccines for which the Shake Test is done (Freeze-Sensitive Vaccines):
- DPT / DPT-HepB-Hib (Pentavalent)
- DT
- TT / Td
- Hepatitis B (HepB)
- IPV (Inactivated Polio Vaccine)
Mnemonic: "DPT, HepB, TT/DT, IPV = Shake Test vaccines" (all contain aluminum adjuvant)
Never do the shake test for OPV or BCG - they are not freeze-sensitive.
Q14. Why must returned/opened/discarded vaccines be kept safely for 48 hours before discarding?
This is directly linked to AEFI (Adverse Events Following Immunization) surveillance.
Reason: If a child develops an adverse reaction (fever, convulsions, anaphylaxis, abscess, or serious event) after vaccination, the health team needs to:
- Identify the exact batch number of the vaccine administered
- Send the remaining vials from that batch for laboratory testing
- Enable investigation of whether the adverse event was vaccine-related, programmatic error-related, or coincidental
- Allow recall of bad batches if a manufacturing defect is detected
If vials are thrown away immediately, there is no way to trace or investigate the event. The 48-hour window covers the period when most serious immediate AEFIs would manifest and be reported.
This is mandated under the National AEFI surveillance guidelines and all discarded vials, empty or returned, must be stored in a separate labeled bag/box for 48 hours at the cold chain point.
Q15. What is Mission Indradhanush / Intensified Mission Indradhanush (IMI)?
Mission Indradhanush (MI):
- Launched on December 25, 2014 by Union Health Minister J.P. Nadda
- Aims to achieve and sustain 90% Full Immunization Coverage (FIC) by targeting unvaccinated and partially vaccinated children under 2 years and pregnant women missed by routine immunization
- Focuses on high-risk districts, urban slums, tribal areas, conflict areas, and hard-to-reach geographies
Intensified Mission Indradhanush (IMI):
- Launched on October 8, 2017 by PM Modi
- Conducted in multiple phases: IMI 1.0, 2.0, 3.0, 4.0, 5.0
- IMI 5.0 was the latest major phase
- Each phase has 3-4 rounds of 7 working days each, targeting residual pockets of low coverage
Why "Indradhanush" (Rainbow) even though it covers more than 7 diseases?
The original Mission Indradhanush was named after the 7-color rainbow because it initially targeted 7 vaccine-preventable diseases (TB/BCG, Polio, DPT-3, HepB, Measles) - symbolizing that vaccination against these 7 diseases would color the lives of children with health and protection.
Over the years, more vaccines have been added under UIP (now 12 VPDs nationally), but the name "Indradhanush" has been retained because:
- The name itself is now a powerful, recognizable brand
- The rainbow metaphor still holds - vaccines represent a spectrum of protection, bringing color/life to children
- The mission's core philosophy remains the same - reaching every child and ensuring full protection
- Changing the name would cause public confusion and dilute the brand equity built over years
Currently under UIP (and thus IMI): BCG, OPV, IPV, DPT (Pentavalent), HepB, MR, PCV, RVV, JE (endemic districts), Td - 12 VPDs nationally
SECTION 2: STATE & NATIONAL HEALTH SCHEMES
Q16. Explain the Namo Shri Yojana
Namo Shri Yojana is a Gujarat state government flagship scheme launched in February 2024 by Chief Minister Bhupendra Patel to provide financial assistance to pregnant women and lactating mothers.
Financial Assistance: ₹12,000 per beneficiary (for first 2 live births)
Eligibility Criteria:
- Must be a resident of Gujarat
- Must be a beneficiary of SC, ST, NFSA (National Food Security Act), or PM-JAY (Pradhan Mantri Jan Arogya Yojana)
- For first two live births only
Disbursement for FIRST pregnancy (₹12,000 in 4 installments):
| Installment | Amount | Condition |
|---|
| 1st | ₹5,000 (₹2,000 state + ₹3,000 Centre/PMMVY) | At registration of pregnancy |
| 2nd | ₹2,000 (state) | After 6 months of pregnancy |
| 3rd | ₹3,000 (state) | After institutional delivery |
| 4th | ₹2,000 (Centre/PMMVY) | After 14th-week immunization of child |
Impact (as of September 2025): Over 6.21 lakh women benefited; ₹354 crore disbursed; ~11 lakh enrolled via TeCHO+ portal. Funds transferred directly to bank accounts via PFMS.
Q17. How does Namo Shri Yojana integrate with PMMVY during second pregnancy?
For the second pregnancy, the structure changes:
| Installment | Amount | Source | Condition |
|---|
| 1st | ₹2,000 | State | At registration |
| 2nd | ₹3,000 | State | At 6 months of pregnancy |
| 3rd | ₹6,000 | Centre (if girl child) / State (if boy child) | After institutional delivery |
| 4th | ₹1,000 | State | After 14th-week immunization |
| Total | ₹12,000 | | |
PMMVY Integration:
- Under the central PMMVY (PM Matru Vandana Yojana), the benefit for the second pregnancy was only available if the second child was a girl (as per revised PMMVY 2.0 guidelines)
- Namo Shri Yojana fills the gap - Gujarat state supplements with its own funds so that even if the second child is a boy, the family receives the full ₹12,000
- The Center and State together provide the complete package - seamlessly integrated through TeCHO+ portal and PFMS for direct bank transfer
Q18. Latest updates in Janani Shishu Suraksha Karyakram (JSSK)
JSSK was launched on June 1, 2011 to provide completely cashless and free services to pregnant women and sick newborns accessing public health facilities.
Core Entitlements (established):
- Free normal delivery and C-section
- Free drugs and consumables
- Free diagnostics (blood, urine, ultrasound)
- Free diet (3 days for normal delivery, 7 days for C-section)
- Free blood transfusion
- Free referral transport (102 Ambulance both ways - from home to facility and back)
- Exemption from all user charges
Entitlements extended to sick newborns (up to 30 days):
- Free treatment, drugs, diagnostics, diet, blood, and transport
Recent updates and current status (2024-2025):
- Integration with Namo Shri Yojana in Gujarat - JSSK beneficiaries are also enrolled for Namo Shri
- 102 ambulance service strengthened - target is 100% two-way transport
- Extension of sick newborn coverage - some states have extended up to 1 year age under state modifications
- Diet entitlement improvement - standardized menus being implemented
- Digital monitoring through Nikshay-like portals for JSSK beneficiaries in several states
- JSSK + NRC (Nutritional Rehabilitation Centre) linkage for SAM children up to 5 years
Important for Gujarat context: Gujarat has its own strong "Mamta Abhiyan" and TeCHO+ system that tracks all JSSK benefits digitally.
Q19. Explain Mukhyamantri Amrutam (MA) Yojana - How is it different from PM-JAY?
Mukhyamantri Amrutam (MA) Yojana is Gujarat's flagship health insurance scheme, launched in 2012, making Gujarat one of the first states to implement a state-level health coverage scheme.
| Feature | MA Yojana (Gujarat) | PM-JAY (Ayushman Bharat) |
|---|
| Launched | 2012 (Gujarat) | 2018 (Central) |
| Coverage | Up to ₹5 lakh per family per year | ₹5 lakh per family per year |
| Beneficiaries | BPL families, SECC-identified, ST communities | Bottom 40% population (50 cr beneficiaries) |
| Diseases | Tertiary care - cardiac, cancer, neuro, burns, renal, trauma | Broader package - 1,961+ health benefit packages |
| Hospital Network | Empanelled public and private hospitals in Gujarat | Pan-India empanelled network |
| Unique Feature | MA Vatsalya Yojana extended to middle class (self-paying segment) | No premium for poor; some states add premium-based tiers |
| State supplement | Gujarat tops up beyond ₹5L for certain critical conditions | No state top-up by default |
| Implementation | State-run through GSHP (Gujarat State Health & Medical Services) | NHA (National Health Authority) implements |
Key difference: MA Yojana is state-managed, state-funded for Gujarat's own BPL and tribal population. PM-JAY is centrally funded (60:40 Centre:State). Gujarat has integrated both - a person can be covered under both MA and PM-JAY, with MA as the state layer on top of PM-JAY. This is called MA-Ayushman Bharat Convergence.
Q20. Recent changes in NTEP (National Tuberculosis Elimination Program)
NTEP replaced RNTCP (Revised National TB Control Programme) in 2020, signaling a shift from "control" to "elimination" by 2025 (and now extended pragmatically to 2030 target).
Key recent updates:
-
Nikshay Poshan Yojana - Enhanced: DBT of ₹1,000/month (increased from ₹500) directly to TB patients for nutritional support
-
New drugs introduced:
- Bedaquiline and Delamanid now available at district level for DR-TB
- BPaL regimen (Bedaquiline + Pretomanid + Linezolid) introduced for XDR-TB
- 6-month shorter MDR-TB regimen (replacing the old 18-20 month regimen)
-
Preventive Treatment scaled up:
- TB Preventive Therapy (TPT) with 6H (6 months Isoniazid) or 3HP (3 months Isoniazid + Rifapentine) for household contacts and PLHIV
- Scaled to 31% of eligible household contacts (2023)
-
100 Days Campaign (2023): Ni-kshay Mitra initiative - corporates, individuals, and NGOs adopt TB patients for nutritional, diagnostic, and vocational support
-
Pradhan Mantri TB Mukt Bharat Abhiyan (2022): Community support linkage for every TB patient
-
Treatment success rates improved: 87% for MDR-TB, 72% for pre-XDR-TB
-
Private sector notification mandatory - penalties for non-notification
-
Molecular diagnostics (CBNAAT/TrueNat) at sub-district level for rapid diagnosis
-
U-WIN and Nikshay integration for seamless beneficiary tracking
Q21. Gujarat's MMR improvement - what specific interventions caused this?
Gujarat's MMR (Maternal Mortality Ratio) has improved significantly. Key interventions:
-
Chiranjivi Yojana (now subsumed under JSSK/NHM): Initially incentivized private practitioners to conduct deliveries for BPL women in remote areas - dramatically increased institutional deliveries
-
Namo Shri Yojana and JSSK convergence: Financial incentives for ANC registration and institutional delivery
-
108/102 ambulance services: Timely referral of obstetric emergencies
-
Surakshit Matrutva Abhiyan: Monthly fixed-day ANC camps at PHCs on 9th of every month - high-risk pregnancy identification
-
MCH (Mother and Child Health) Wing strengthening: Dedicated MCH wings at CHCs and DHs with SNCUs and OTs
-
Blood Bank linkage: Every delivery point linked to nearest blood bank; remote blood storage units installed
-
Skill training of nursing staff: Emergency Obstetric Care (EmOC) training for staff nurses and Medical Officers
-
TeCHO+ portal: Real-time tracking of every pregnant woman from registration to delivery and 42-day postnatal follow-up
-
High-risk pregnancy identification: ANCs at sub-centre level with standardized color coding (red = high risk, referred immediately)
SECTION 3: SITUATIONAL & BEHAVIORAL / CONFLICT RESOLUTION
Q22. Managing vaccine hesitancy - mother refuses immunization
Use the AABC approach (Acknowledge, Ask, Be empathetic, Communicate):
Step 1 - Don't argue immediately. Acknowledge her concern:
"I understand you've heard things that worry you. It's natural for a mother to be concerned about her child's safety."
Step 2 - Ask specifically what she has heard:
Find out the specific myth - is it about fever, infertility, containing haram ingredients, or general distrust?
Step 3 - Counter with simple, relatable evidence:
- "Your baby has already faced much harder things - growing inside you for 9 months, the birth itself. A small prick is nothing compared to what measles, polio or tetanus can do."
- Show the VVM, explain that vaccines are checked for safety
- Share community success stories - "Your neighbor Savita's child got vaccinated - see how healthy he is"
- Involve ASHA/Anganwadi worker as a known, trusted face in the community
Step 4 - Involve a respected influencer:
- Village Sarpanch, Anganwadi worker, a community elder, or a respected local doctor
- Religious leaders if faith-based hesitancy is involved
Step 5 - Offer choice, not coercion:
"Would you like to watch as I vaccinate another child first, so you can see that it is safe?"
If she STILL refuses after counseling:
- Do NOT force or threaten - this is counterproductive and unethical
- Document the refusal clearly in the Immunization Register and family folder
- Flag as zero-dose child in the Nikshay/HMIS/U-WIN system
- Ensure ASHA follows up in the next 2 weeks
- Revisit at next session - hesitancy is often overcome over time
- Inform BMO if systematic hesitancy is detected in the community - may need a community sensitization camp with local leaders
Q23. Managing conflict between ASHA worker and MPHW at your PHC
Use the STAR-I Conflict Resolution framework:
S - Stop the conflict immediately:
- Separate both parties if the conflict is heated
- Ensure it does not happen in front of patients or community members
T - Talk to each person privately:
- Hear both sides individually, without bias
- Do not take sides at this stage
- Understand the root cause: is it role overlap, workload, personal, or resource-related?
A - Analyze the root cause:
- Most ASHA-MPHW conflicts arise from: unclear role boundaries, incentive-sharing disputes, overlapping catchment areas, communication gaps, or personal ego clashes
- Identify if it is a systemic issue or individual issue
R - Resolve with clarity:
- Call a joint meeting - present the official role descriptions of ASHA and MPHW (they are complementary, not competing)
- ASHA = community mobilizer, counselor, link worker (accredited social health activist)
- MPHW (Female) = sub-centre level health worker, clinical services
- Redistribute tasks clearly if there is overlap
- If incentive dispute - refer to official ASHA incentive guidelines
I - Implement and follow up:
- Document the resolution
- Follow up in the next monthly PHC team meeting
- If the conflict persists or is serious, escalate to the BMO (Block Medical Officer)
As PHC Medical Officer, your stance must be:
"I am not a judge - I am a facilitator. Both of you are essential to our team and to the community. Let us focus on the patient, not on the dispute."
Q24. Sudden rise in diarrhea cases in a tribal village - STAR-I Framework
STAR-I = Situation, Task, Action, Result, Improvement
S - Situation Assessment (First 24-48 hours):
- Confirm the outbreak: Are these new, clustered cases? What is the usual baseline?
- Rapid case count: How many cases? How many severe? Any deaths? Age group affected?
- Geographic mapping: Are cases from one water source/area or scattered?
- Time-cluster-place analysis
T - Task/Immediate Notification:
- Inform BMO, CHO, District Surveillance Unit (DSU) under IDSP (Integrated Disease Surveillance Programme)
- File S-form (Syndromic reporting) and P-form (Probable case reporting) immediately
- Activate the Rapid Response Team (RRT) at the district level
A - Action (Field Response):
Case management:
- Set up ORS corner / temporary treatment area at the village
- Ensure ORS packets distributed to every affected household
- Zinc supplementation for children under 5 with diarrhea
- IV fluids for severe dehydration (Ringer's Lactate)
- Refer severe cases to CHC/DH
Source identification:
- Collect stool samples from 5-10 cases for lab testing
- Collect water samples from the common water source
- Identify if there was a recent social event (feast, wedding) - food-borne outbreak?
Preventive actions:
- Chlorinate the water supply (0.5 mg/L residual chlorine at point of use)
- Conduct household-level health education on hand hygiene, ORS preparation, safe water storage
- Involve ASHA and Anganwadi workers for house-to-house surveillance
- Suspend the suspected contaminated water source if confirmed
R - Result monitoring:
- Daily case reporting to DSU for minimum 2 incubation periods after last case
- Track treatment outcomes, hospital admission rates
- Confirm lab results - is this cholera, rotavirus, salmonella, or ETEC?
I - Improvement / Post-outbreak:
- Root cause analysis report
- Permanent water treatment/sanitation improvement plan
- Community sensitization
- VHSNC (Village Health Sanitation and Nutrition Committee) activation for Swachh Bharat activities
- After-action review with the PHC team
SECTION 4: IMNCI & CLINICAL PROTOCOLS
Q25. Four "General Danger Signs" in a sick child (2 months to 5 years) - IMNCI
Under IMNCI, before assessing any specific illness, ALWAYS check the 4 General Danger Signs (GDS) first:
| # | Danger Sign | What it means |
|---|
| 1 | Not able to drink or breastfeed | Unable to swallow, extremely weak - indicates severe illness |
| 2 | Vomits everything | Cannot retain any oral intake - dehydration risk, meningitis, obstruction |
| 3 | Convulsions (in current illness) | Seizures - indicates brain involvement: meningitis, hypoglycemia, febrile seizure |
| 4 | Lethargic or unconscious | Altered sensorium - severe sepsis, meningitis, encephalopathy |
If ANY one of these 4 signs is present:
- The child is classified as having a SERIOUS condition requiring urgent referral
- Give pre-referral treatment and refer IMMEDIATELY
- Do NOT delay for detailed assessment
Mnemonic: "Very Sick Children Leave" - Vomits everything, Severe lethargy/unconscious, Convulsions, Can't drink/breastfeed
Q26. Fast Breathing cutoffs in IMNCI
| Age Group | Fast Breathing Cutoff (Respiratory Rate) |
|---|
| Under 2 months | ≥ 60 breaths/minute |
| 2 months to 12 months | ≥ 50 breaths/minute |
| 12 months to 5 years | ≥ 40 breaths/minute |
For the specific ages asked:
- 8-month-old infant: Fast breathing = ≥ 50 breaths/minute (age 2-12 months)
- 3-year-old child: Fast breathing = ≥ 40 breaths/minute (age 12 months to 5 years)
Important: Count respiratory rate for a full 60 seconds when the child is calm. If fast breathing is present WITHOUT chest in-drawing, classify as Pneumonia (non-severe) - treat with Amoxicillin and follow up. If chest in-drawing or danger signs present - classify as Severe Pneumonia - pre-referral treatment and refer.
Q27. IMNCI Plan A - 4 Rules of Home Treatment for Diarrhea
Under Plan A (for children with diarrhea but NO signs of dehydration), teach the mother 4 rules of home treatment:
Rule 1: Give More Fluids
- Give ORS after each loose stool
- Children under 2 years: 50-100 ml after each stool
- Children 2-10 years: 100-200 ml after each stool
- Continue breastfeeding
- Other home fluids: rice water, dal water, plain water
Rule 2: Give Zinc Supplementation
- Children under 6 months: 10 mg zinc/day for 14 days
- Children 6 months and above: 20 mg zinc/day for 14 days
- This reduces duration and severity of the episode and prevents recurrence for 2-3 months
Rule 3: Continue Feeding
- Do NOT stop eating - starvation worsens recovery
- Give nutritious, easily digestible food - khichdi, dal-rice, banana, curd
- Breastfed infants: increase breastfeeding frequency
Rule 4: Return Immediately (When to Return)
Teach the mother danger signs to return immediately if child:
- Cannot drink or is drinking poorly
- Vomits repeatedly
- Has bloody stools
- Has fever
- Is not better after 3 days
Q28. Zinc supplementation dosage - IMNCI
| Age | Dose | Duration | Purpose |
|---|
| Under 6 months (e.g., 4-month-old) | 10 mg/day | 14 days | For diarrhea treatment |
| 6 months and above (e.g., 3-year-old) | 20 mg/day | 14 days | For diarrhea treatment |
For the specific ages asked:
- 4-month-old infant: 10 mg zinc per day for 14 days
- 3-year-old child: 20 mg zinc per day for 14 days
Zinc dispersible tablets (20 mg dispersible tablet): Dissolve in small amount of breast milk/ORS/water before giving.
Note: Zinc supplementation reduces diarrhea duration by approximately 25%, reduces severity, and provides protection against future diarrheal and respiratory episodes for up to 2-3 months by boosting innate immunity.
Q29. Pre-referral treatment for young infant (under 2 months) with "Possible Serious Bacterial Infection"
Under IMNCI for young infants (0-2 months), Possible Serious Bacterial Infection (PSBI) is classified when ANY of these signs are present: fast breathing, severe chest in-drawing, movement only when stimulated or no movement at all, not feeding well, bulging fontanelle, convulsions, fever (≥38°C) or hypothermia (<35.5°C), history of unable to feed since birth.
Pre-referral treatment protocol:
- IM Ampicillin (or Benzylpenicillin): 50 mg/kg IM immediately as first dose
- IM Gentamicin: 5 mg/kg IM immediately as first dose
- If referral is refused or distance is too great: Initiate Gentamicin IM once daily + Amoxicillin oral BD for 7 days (simplified treatment protocol for non-referral situations - PSBI protocol where referral not possible)
- Treat fever: If fever ≥38°C, Paracetamol
- Prevent hypoglycemia: Give warm breastmilk/expressed breast milk; keep warm (Kangaroo Mother Care)
- Prevent hypothermia: Wrap, skin-to-skin contact
- Do NOT give oral medications if baby cannot swallow
- Refer URGENTLY to first referral unit (FRU)
If convulsions: IM/IV Phenobarbitone 20 mg/kg as pre-referral
Q30. Prophylactic Vitamin A Schedule (Under 5 years)
| Dose | Age | Amount | Formulation |
|---|
| 1st dose | 9 months (with MR-1) | 1 lakh IU (100,000 IU) | Oral liquid |
| 2nd dose | 16 months (with MR-2/DPT booster) | 2 lakh IU (200,000 IU) | Oral liquid |
| 3rd dose | 24 months | 2 lakh IU | Oral liquid |
| 4th dose | 30 months | 2 lakh IU | Oral liquid |
| 5th dose | 36 months | 2 lakh IU | Oral liquid |
| 6th dose | 42 months | 2 lakh IU | Oral liquid |
| 7th dose | 48 months | 2 lakh IU | Oral liquid |
| 8th dose | 54 months | 2 lakh IU | Oral liquid |
| 9th dose | 60 months (5 years) | 2 lakh IU | Oral liquid |
Total: 9 doses under UIP until 5 years of age
Key point: First dose at 9 months is 1 lakh IU (half dose compared to subsequent doses). All subsequent doses from 16 months onwards are 2 lakh IU, given every 6 months.
Vitamin A supplementation reduces all-cause child mortality by ~12-24% and is especially important in areas with high VAD (Vitamin A Deficiency).
Q31. Kangaroo Mother Care (KMC) / Skin-to-Skin Contact for Hypothermic Infant
How to instruct a mother to provide KMC:
Definition: KMC is a method of care for stable low-birth-weight and premature infants where the baby is held skin-to-skin against the mother's chest in an upright position continuously.
Step-by-step instructions to the mother:
-
Position: Place the baby upright between your breasts, on your bare chest, directly skin-to-skin. Baby's head is turned to one side, resting on your chest (so the ear is against your heart)
-
Baby's position: Baby's hips and knees should be flexed (frog-like position) - this is the most stable and comfortable position for the baby and helps maintain temperature
-
Securing the baby: Wrap a cloth/kangaroo wrap firmly around both of you - the baby's body from ears to bottom should be within the cloth. The face should be visible and not covered
-
Duration: Maintain KMC as continuously as possible - 24 hours a day, for weeks if needed (especially in NICU settings). Even in the field, 1-2 hours of continuous KMC can bring a hypothermic baby's temperature to normal
-
Breastfeeding: Can breastfeed in KMC position by tilting the baby slightly. Encourage frequent breastfeeding to prevent hypoglycemia in hypothermic infants
-
When to seek help: If baby remains cold after 1 hour of KMC, does not suck, turns blue or pale, has difficulty breathing - refer immediately
Temperature target: Normal axillary temperature in a neonate is 36.5°C to 37.5°C. Check every 15-30 minutes when treating hypothermia.
Benefits of KMC (for the interview): Stabilizes temperature, promotes breastfeeding, reduces infections, reduces hypoglycemia, promotes mother-infant bonding, reduces mortality in LBW infants.
Q32. IMNCI Breastfeeding Assessment - 4 Signs of Good Attachment
When assessing breastfeeding under IMNCI, you look for:
4 Signs of GOOD Attachment:
- Chin touching the breast (or very close to it)
- Mouth wide open
- Lower lip turned outward (everted)
- More areola visible ABOVE the mouth than below (more of the upper areola should be visible)
Mnemonic: "CALM" = Chin, Areola, Lip, Mouth
Signs of POOR attachment (red flags):
- Only the nipple in the mouth (not the areola)
- Lower lip turned inward
- Chin away from breast
- Cheeks pulled inward (sucking cheeks in = ineffective latch)
Additional breastfeeding assessment points:
- Is the baby sucking effectively? (Slow deep sucks with pauses, not rapid shallow sucking)
- Is the baby positioned correctly? (Baby facing mother, body aligned, nose at nipple level before latching)
- Any breastfeeding problems? Sore nipples, engorgement, or perceived insufficient milk?
Common breastfeeding problems and management:
| Problem | Management |
|---|
| Sore nipples | Correct positioning and attachment; apply breast milk on nipple after feeds |
| Engorgement | Frequent feeding, warm compress, hand expression |
| Inverted nipples | Breast shells, Hoffman's technique |
| Perceived low milk | Reassurance, increase feed frequency, ensure adequate maternal nutrition/hydration |
SECTION 5: HR & PERSONAL QUESTIONS
Q33. Tell Me About Yourself (5P Formula)
(Adapt to your own actual details - this is the framework with suggested content)
P1 - Profile:
"I am Dr. [Your Name], a medical graduate from [College Name, Gujarat], currently pursuing my MD in Community Medicine at [Institution]. I am passionate about preventive healthcare and public health systems."
P2 - Professional Journey:
"During my MBBS, I was particularly drawn to Community Medicine and Public Health postings - I found the work happening at the grassroots level far more impactful than I had expected. My rural posting at [PHC name] opened my eyes to the real challenges and also the real opportunities in primary healthcare. I chose Community Medicine for my PG specifically because I wanted to understand the system from the inside."
P3 - Passion:
"I am deeply interested in maternal and child health, vaccine-preventable disease control, and the functioning of grassroots health systems. I believe the most important battleground for India's health outcomes is the PHC and sub-centre level - not tertiary hospitals."
P4 - Proof of capability:
"During my [internship/PG posting], I was responsible for [specific achievement - e.g., organizing immunization camp, identifying outbreak, improving ANC registration rate]. This taught me how to work with communities, coordinate with health teams, and solve real field problems."
P5 - Purpose:
"I am here today because I want to serve the people of Gujarat at the ground level as a government Medical Officer. I believe government service gives me the scale, the mandate, and the resources to create genuine public health impact - something a private practice cannot offer."
Q34. Why government service when you're already doing PG in Community Medicine?
PREP Framework:
P - Point:
"My choice to pursue this position now, alongside my PG in Community Medicine, is not a conflict - it is a natural continuation. Community Medicine is the discipline that exists precisely to inform and improve public health systems, and government service is where that discipline comes alive."
R - Reason:
"Community Medicine gives me the academic and epidemiological understanding of what should be done. A government MO position gives me the authority and the mandate to actually do it. The two complement each other perfectly. The skills I build in government service - field management, community mobilization, program implementation, crisis response - will make me a better researcher and academician, and vice versa."
E - Example:
"In my field postings, I have seen Community Medicine concepts - social determinants, health system strengthening, IMNCI protocols - that exist beautifully on paper but are inconsistently implemented on the ground. As a government MO, I can be the bridge between the evidence and the implementation."
P - Point (closing):
"I am not choosing government service instead of my academic career - I am choosing it as the natural extension of what Community Medicine teaches. Serving in a government PHC is, in many ways, the most authentic form of practicing community medicine."
Q35. Why government service instead of private clinic or strict academic MD work?
Three honest and powerful points:
1. Scale of Impact:
"A private practice may allow me to serve 50-100 patients a day - and I respect that work. But as a government Medical Officer, I am responsible for the health of 30,000-50,000 people in my PHC's catchment area. I am responsible for their immunization, their maternal care, their disease surveillance, their access to essential medicines. The scale of impact is simply incomparable."
2. Equity and Access:
"The people who come to government facilities are the ones who have no other option - tribal women, agricultural laborers, seasonal migrants. If a skilled, committed doctor is not at that PHC, they have nowhere to go. Private medicine naturally gravitates toward urban, affluent populations. My skills are most needed - and most impactful - in the public system."
3. System Change from Inside:
"Purely academic MD work produces knowledge - which is essential. But knowledge must be translated into practice. Government service allows me to implement evidence-based protocols, improve local health indicators, train ASHAs and ANMs, and contribute to data that feeds back into research. The academic and the operational are not separate - they are a cycle. I want to be part of that entire cycle, not just one end of it."
Q36. What is your vision for rural healthcare?
"My vision for rural healthcare in Gujarat rests on three pillars:
1. A functional, respected PHC as the community's first and often only health home:
The PHC should not be a gateway that just says 'refer to district hospital.' It must be capable of managing 80% of common illnesses, conducting safe deliveries, providing all UIP vaccines reliably, managing minor surgical procedures, and diagnosing common NCDs. A PHC that people trust enough to actually use is the single most powerful intervention for rural health.
2. Community-owned health behavior:
The best healthcare system fails if the community does not engage with it. My vision includes active VHSNCs, empowered ASHAs who are genuinely respected in their communities, and a population that understands when to seek care, how to use ORS, why vaccines matter, and what symptoms require urgent attention.
3. Data-driven local governance:
Every PHC should know its own key health indicators - ANC registration rate, FIC coverage, MMR, IMR, NCD screening coverage. Not as numbers to file upward, but as tools for self-assessment and improvement. A Medical Officer who tracks these data points, identifies gaps, and works systematically to close them is a far better MO than one who simply sees patients passively.
Gujarat has the infrastructure, the political will, and tools like TeCHO+, U-WIN, and eVIN. My role is to make these systems work for the last person in the last hamlet."
Q37. Your greatest strengths as a doctor?
(Frame 3 concrete, verifiable strengths with examples - avoid generic answers)
Strength 1: Systems Thinking with Field Sensitivity
"I am trained to see healthcare not just patient by patient, but population by population. I understand that a rise in malnutrition at the anganwadi level, a drop in ANC registrations, and an increase in preterm births might all be connected to the same root cause. This systems perspective, combined with field exposure, allows me to identify solutions that are practical and not just theoretically sound."
Strength 2: Communication across social barriers
"Having worked in rural and tribal areas during my postings, I have learned to communicate health information across literacy levels, languages, and cultural contexts. I can explain vaccine science to a skeptical tribal mother, and I can write a policy brief for a district health officer - and mean it the same way in both conversations. This is the core communication skill that a government MO needs more than any other."
Strength 3: Composure and protocol adherence under pressure
"In field emergencies - an obstetric complication at night, an outbreak call, a vaccine cold chain failure - the strongest clinical skill is the ability to follow the right protocol calmly and quickly. I have trained myself to assess first, act by protocol, and then troubleshoot. This reduces error and builds team confidence. I do not improvise when a protocol exists - I use it."
QUICK REVISION SUMMARY TABLE
| Topic | Key Numbers to Remember |
|---|
| ILR temperature | +2°C to +8°C |
| Deep Freezer temperature | -15°C to -25°C |
| Ice packs in vaccine carrier | 4 packs |
| Conditioning = ice pack ready when | Swishing sound heard = 0°C |
| OVP - Reconstituted vaccines discard | 4 hours |
| Vaccines NOT in OVP | BCG, MR, JE (reconstituted) |
| eVIN cold chain points | 29,000+ live on eVIN |
| Namo Shri Yojana amount | ₹12,000 per beneficiary |
| Namo Shri launch | February 2024 |
| JSSK launch | June 1, 2011 |
| Mission Indradhanush launch | December 25, 2014 |
| IMI 1.0 launch | October 8, 2017 |
| UIP VPDs covered currently | 12 nationally |
| IMNCI General Danger Signs | 4 signs (VSCL) |
| Fast breathing - 8 months | ≥50/min |
| Fast breathing - 3 years | ≥40/min |
| Zinc under 6 months | 10 mg/day × 14 days |
| Zinc 6 months and above | 20 mg/day × 14 days |
| Vitamin A - 1st dose (9 months) | 1 lakh IU |
| Vitamin A - subsequent doses | 2 lakh IU every 6 months |
| Total Vitamin A doses under 5 | 9 doses |
| VVM - measures | Cumulative heat (NOT current temperature) |
All the best for your GPSC interview! This answer bank covers all 37 questions in detail. For each question, I recommend practicing the answer aloud 2-3 times so the response flows naturally rather than sounding memorized. The panel will appreciate when you connect field experience to the protocols you describe.